Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 68,100 shares at $26.78 ($1.8M) on 2018-05-10, disclosed to the SEC on 2018-05-14.
Open-market sale of $1.8M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.78 | 6,620 | $177K | 9.7% |
| 2 | $26.78 | 6,620 | $177K | 9.7% |
| 3 | $26.78 | 26,480 | $709K | 38.9% |
| 4 | $26.78 | 26,480 | $709K | 38.9% |
| 5 | $27.52 | 380 | $10K | 0.6% |
| 6 | $27.52 | 1,520 |
| $42K |
| 2.3% |
| Total | $26.80 avg | 68,100 | $1.8M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |